Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell CarcinomaCells 2022 Aug 12;[EPub Ahead of Print], Y Zhang, P Kumar, JJ Adashek, WP Skelton, J Li, A Vosoughi, J Chahoud, BJ Manley, PE Spiess
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.